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Dan Xing†, Yang Yang†, Xinlong Ma*, Jianxiong Ma*, Baoyi Ma and Yang ChenAbstract
Background: Intraarticular steroid injections are widely used in joint arthritis. However, the data regarding an
association between an increased risk for arthroplasty infection after an intraarticular steroid injection are still
conflicting. We conducted a meta-analysis to evaluate the evidence from relevant studies that examine the relation
between intraarticular steroid injections and infection rates in subsequent joint arthroplasty and to develop GRADE
based recommendations for using the steroid before arthroplasty.
Methods: A systematic search of all studies published through August 2014 was conducted using the MEDLINE,
EMBASE, OVID, ScienceDirect and Cochrane CENTRAL databases. The relevant studies that examined the relation
between intraarticular steroid injections and infection rates in subsequent joint arthroplasty were identified.
Demographic characteristics, infection rates and clinical outcomes were manually extracted from all of the selected
studies. The evidence quality levels and recommendations were assessed using the GRADE system.
Results: Eight studies looking at hip and knee arthroplasties were included. Meta-analysis showed that patients
with steroid injection before arthroplasty had a higher deep infection rate than patients without steroid injection
(OR = 2.13, 95% CI 1.02-4.45), but no significant effect on superficial infection rate (OR = 1.75, 95% CI 0.74-4.16). The
overall GRADE system evidence quality was very low, which lowers our confidence in their recommendations.
Conclusions: Intraarticular steroid injections may lead to increased deep infection rates of subsequent joint
arthroplasty but not the superficial infection rates. Due to the poor quality of the evidence currently available,
further studies are still required.
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Intraarticular steroid injections can be administered for
diagnostic [1-4] and therapeutic reasons [5-8]. Particularly,
they were widely used to alleviate inflammatory symptoms
that can be associated with moderate or end-stage osteo-
arthritis of the joint. Compared with the injection of a
long-acting anesthetic, steroids can be used for diagnostic
purposes to distinguish intrinsic from extrinsic sources of
pain such as that originating in the spine [1-4]. The dur-
ation and efficacy of pain relief then can be indicative of
the source of pain [5-8]. Intraarticular steroid injections* Correspondence: tjmuld@gmail.com; mjx969@163.com
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unless otherwise stated.can be helpful in clinical practice when patients with mod-
erate or end-stage osteoarthritis are not willing or suitable
to undergo an arthroplasty in the short term [9].
However, there have been several adverse effects re-
ported with the use of steroid, such as tendon rupture
[10,11] and increased risk of joint infection in subse-
quent arthroplasty [12]. Given the potentially devastating
outcomes of arthroplasty infection, determining whether
such a relation exists is of high clinical importance. Sev-
eral clinical studies have been conducted to examine this
issue previously. Two studies [13,14] showed more infec-
tions in a group of patients who had an intraarticular
steroid injection in the hip before they had an arthro-
plasty. While, other two studies [15,16] demonstrated
that there was no increase in infection rates in patientsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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steroid into the joint.
At present, the data regarding an association between
an increased risk for arthroplasty infection after an intraar-
ticular steroid injection are still conflicting. Therefore, the
purpose of the present meta-analysis is to evaluate the evi-
dence from relevant studies that examine the relation be-
tween intraarticular steroid injections and infection rates
in subsequent joint arthroplasty and to develop GRADE
(Grading of Recommendations, Assessment, Develop-
ment, and Evaluation) based recommendations for using
the steroid before arthroplasty [17,18].
Material and methods
Search strategy
To assemble all of the relevant published studies, PRISMA
compliant searches of MEDLINE, EMBASE, ScienceDirect,
OVID, the Cochrane CENTRAL database and Google
scholar were performed for all peer-reviewed studies pub-
lished through Aug 2014 that examine the relation between
intraarticular steroid injections and infection rates in subse-
quent joint arthroplasty. The following search terms were
used to maximize the search specificity and sensitivity: in-
jection, arthroplasty, infection, replacement, steroid, hip
and knee.
Secondary searches of the unpublished literature were
conducted by searching the WHO International Clinical
Trials Registry Platform, UK National Research Register
Archive, and Current Controlled Trials from their incep-
tion to August 1, 2014. The reference lists of all the full
text papers were examined to identify any initially omit-
ted studies. We made no restrictions on the publication
language.
Inclusive and exclusive criteria
Studies were included if they compared the infection rates
of joint arthroplasties in cohorts of joint arthroplasties that
had previous intraarticular steroid injection, with the in-
fection rates in cohorts of joint arthroplasties that had no
previous steroid injection. Single case reports, reviews,
and non-comparable studies were excluded.
Study selection
Two reviewers (D.X. and Y. Y.) independently screened the
titles and abstracts for the eligibility criteria. Subsequently,
the full text of the studies that potentially met the inclusion
criteria were read and the literature was reviewed to deter-
mine the final inclusion. We resolved disagreements by
reaching a consensus through discussion.
Date extraction
Two of the authors (D.X. and Y. Y.) independently ex-
tracted the following data from each full-text report using
a standard data extraction form. The data extracted fromstudies included the title, authors, study design, prosthesis,
steroid injection, time from injection to surgery, duration
of follow-up, and outcomes parameters. The correspond-
ing authors of the included studies were contacted to ob-
tain any required information that was missing. The
extracted data were verified by XL. M.
Outcomes
Deep infection rate and superficial infection rate were
the outcomes of the present study.
Assessment of methodological quality
Following the Cochrane Handbook for Systematic Re-
views of Interventions 5.0, the methodological quality of
the included studies was independently assessed by two
authors (D.X. and Y. Y.). Any disagreements were re-
solved by discussion. A third author (XL. M.) was the
adjudicator when no consensus could be achieved. The
methodological quality was assessed using the methodo-
logical index for non-randomized studies (MINORS)
form [19], which was a valid instrument designed to as-
sess the quality of comparative or non-comparative non-
randomized controlled trials.
Data analysis
We performed all of the meta-analyses with STATA 12.0
(Statacorp, college station, Tex). Odds ratio (OR) and
95% confidence intervals (CIs) were used to evaluate the
dichotomous outcomes. A P-value <0.05 was considered
statistically significant.
Statistical heterogeneity was assessed using Q statistics.
A fixed-effects (inverse variance) model was used when
the effects were assumed to be homogenous (P >0.05).
P <0.05 implied statistical heterogeneity, and a random ef-
fects model was used in those circumstances.
Evidence synthesis
The evidence grade was determined using the guidelines
of the GRADE (Grading of Recommendations, Assess-
ment, Development, and Evaluation) working group [17].
Although the GRADE system acknowledges the primacy
of RCTs, it also recognizes circumstances in which obser-
vational studies generate high quality evidence of treat-
ment effects [20]. The GRADE system uses a sequential
assessment of the evidence quality that is followed by an
assessment of the risk-benefit balance and a subsequent
judgment on the strength of the recommendations. The
evidence grades are divided into the following categories:
(1) high, which indicates that further research is unlikely
to alter confidence in the effect estimate; (2) moderate,
which indicates that further research is likely to signifi-
cantly alter confidence in the effect estimate and may
change the estimate; (3) low, which indicates that further
research is likely to significantly alter confidence in the
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low, which indicates that any effect estimate is uncertain.
Uniformity of the estimated effects across studies and the
extent to which the patients, interventions, and outcome
measures are similar to those of interest may lower or
raise the evidence grade. As recommended by the GRADE
working group, the lowest evidence quality for any of the
outcomes was used to rate the overall evidence quality.
The evidence quality was graded using the GRADEpro
Version 3.6 software. The strengths of the recommenda-
tions were based on the quality of the evidence.
Results
Search results
A total of 1461 titles and abstracts were preliminarily
reviewed, of which 8 studies [13,14,16,21-25] eventually
satisfied the eligibility criteria (Figure 1). One of the
eight studies [22] published in abstract form. Six studies
[13,14,16,22,23,25] evaluated infection rates in total hip
arthroplasties (THA) and two studies [21,24] in total
knee arthroplasties (TKA).
Quality assessment
All studies had a high risk of bias resulting from study de-
sign limitations. The methodological quality assessments
of the included studies used a MINORS form. The MI-
NORS quality scores are presented in Table 1. The mean
score was 11.8 (range, 8–14), which corresponded to aFigure 1 The study selection and inclusion process.49% score. This result indicated that there was consider-
able variability in the evidence base.
Demographic characteristics
In total, eight retrospective cohort studies with 2909
total patients were eligible for inclusion. The individual
sample sizes ranged from 80 to 1317 patients. All in-
cluded studies reported the rate of deep infection after
arthroplasty, while six also reported the rate of supercrit-
ical infection. The demographic characteristics of the
included studies are summarized in Table 2.
Outcome analyses
Deep infection rate
The deep infection rates for each analyzed studies were
0–10% in the injected group and 0–1.3% in the control
group respectively. Meta-analysis showed that patients
with steroid injection before arthroplasty had a higher
deep infection rate than patients without steroid injec-
tion (OR = 2.13, 95% CI 1.02-4.45) (Figure 2).
Superficial infection rate
The superficial infection rates for each analyzed studies
were 0–22.2% in the injected group and 0.4–11.1% in
the control group respectively. Meta-analysis showed
that steroid injection prior to joint arthroplasty had no
significant effect on superficial infection rate (OR = 1.75,
95% CI 0.74-4.16) (Figure 3).
Table 1 The study designs and MINORS appraisal scores for the included studies
Study Study design MINORS methodological criteria Total
1 2 3 4 5 6 7 8 9 10 11 12
Kaspar et al. Retrospective cohort 2 0 0 1 1 2 0 0 2 2 2 1 13
Papavasiliou et al. Retrospective cohort 2 1 0 1 0 2 1 0 2 2 1 1 13
McIntosh et al. Retrospective cohort 2 0 0 1 1 2 0 0 2 2 1 1 12
Sreekumar et al. Retrospective cohort 1 1 0 1 0 2 0 0 2 2 0 1 10
Desai et al. Retrospective cohort 2 1 0 1 0 2 0 0 2 2 0 1 11
Haughton et al. Retrospective cohort 2 1 0 2 0 1 1 0 2 2 1 1 13
Meermans et al. Retrospective cohort 2 0 0 1 0 1 0 0 2 1 0 1 8
Croft et al. Retrospective cohort 2 1 0 2 0 2 0 0 2 2 2 1 14
The MINORS criteria include the following items: (1) a clearly stated aim; (2) inclusion of consecutive patients; (3) prospective data collection; (4) endpoints
appropriate to the aim of the study; (5) unbiased assessment of the study endpoint; (6) a follow-up period appropriate to the aims of the study; (7) less than 5%
loss to follow-up; (8) prospective calculation of the sample size; (9) an adequate control group; (10) contemporary groups; (11) baseline equivalence of groups;
and (12) adequate statistical analyses.
The items are scored as follows: 0 (not reported); 1 (reported but inadequate); or 2 (reported and adequate). The ideal global score for comparative studies is 24.
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The two outcomes in this meta-analysis were evaluated
using the GRADE system. The evidence quality for each
outcome was low or very low (Table 3). Therefore, we
agreed that the overall evidence quality was very low. This
finding may lower the confidence in any recommendations.
Discussion
Infection is a major complication of a total joint arthro-
plasty. It occurs in only a small number of patients but re-
sults in substantial morbidity and a decline in functional
outcome. An increased risk of postoperative infection after
intraarticular steroid injection has been previously
questioned with some clinical studies [13,14]. Several
studies reported that intraarticular steroid injectionTable 2 The demographic characteristics of the included stud
Study Study design Prosthesis Steroid injection Tim
in
to
Kaspar et al. Retrospective
cohort
THA 80 mg methylprednisolone 0.5
Papavasiliou et al. Retrospective
cohort
TKA NR NR
McIntosh et al. Retrospective
cohort
THA 6–40 mg drug
(not mentioned)
11
Sreekumar et al. Retrospective
cohort
THA 80 mg depomedrone 14
Desai et al. Retrospective
cohort
TKA 80 mg depomedrone 12
Haughton et al. Retrospective
cohort
THA 80 mg depomedrone or
40 mg triamcinolone
NR
Meermans et al. Retrospective
cohort
THA 80 mg depomedrone +5–
15 mg levobupivacaine
12
Croft et al. Retrospective
cohort
THA 40 mg depomedrol +4 ml
2% xylocaine
5.9
THA, total hip arthroplasty; TKA, total knee arthroplasty; NR, not reported.may lead to increase arthroplasty infection rates. This
may be due to failure of the steroid to dissolve which
may thus persist and cause local immunosupression fol-
lowing joint arthroplasty [13,24]. Several studies re-
ported that it may be related to contamination of the
joint by the injection process [26]. However, Other stud-
ies demonstrated that there was no association between
previous steroid injections and infection after subsequent
joint arthroplasty [16,21,23]. Because infection rate of joint
arthroplasty is an infrequent event [27], the failure of some
studies that demonstrate such association may be related
to the small number of patients included and hence low
statistical power.
Meta-analysis is used as the main method in the










Injected Control Injected Control
-42.9 months 4/40 0/40 NR NR (9.9-86.2) months
3/54 0/90 12/54 10/90 1 year
2 ± 81 days 3/224 1/224 11/224 8/224 NR
months 0/68 1/136 0/68 1/136 25-33 months
months 0/90 0/180 2/90 5/180 1-6 years
4/254 14/1063 11/254 4/1063 NR
months 1/175 1/175 5/175 7/175 12-131 months
months 0/48 0/48 NR NR 1.4-54.1 months
Figure 2 The odds ratio (OR) estimate for deep infection rate.
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can enhance statistical power and enlarger sample size
by combining original studies, which could provide more
robust evidence. Therefore, we conducted a meta-
analysis to evaluate the evidence from relevant studies
that examine the relation between intraarticular steroid
injections and infection rates in subsequent joint arthro-
plasty. Furthermore, there have been no guidelines or
recommendations for intraarticular steroid injections
before joint arthroplasty. Therefore, there is a need
for an evidence base to help surgeons make clinical
decisions and develop optimal treatments before jointFigure 3 The odds ratio (OR) estimate for superficial infection rate.arthroplasty. To the best of our knowledge, this study is
the first meta-analysis to use the GRADE system to
evaluate the quality of the evidence evaluating the influ-
ence of intraarticular steroid injections on infection rate
before joint arthroplasty.
Because of the challenges clinicians face from the lack
of randomized surgical trials and the large number
of observational surgical studies, retrospective studies
were included in this meta-analysis. However, including
retrospective studies in the present study introduces
a high risk of bias. The methodological quality assess-
ment identified a number of limitations to the current
Table 3 The GRADE evidence quality for each outcome













































Xing et al. Journal of Orthopaedic Surgery and Research 2014, 9:107 Page 6 of 7
http://www.josr-online.com/content/9/1/107evidence base. Combining the results of the observa-
tional studies could cause significant bias. To some
extent, the observational studies included in this study
may overestimate the actual effect. Moreover, confound-
ing factors that should be balanced by randomized
methods disturbed the intervention effect in the retro-
spective studies. Therefore, most of the included studies
had relatively high methodological assessment risks,
which may have influenced the accuracy and reliability
of the pooled results.
Some degree of clinical heterogeneity was induced by
the different surgical technologies used, surgical site, med-
ical co-morbidities, nutritional status of patients, surgical
duration, admission to the hospital from a healthcare facil-
ity, pre-surgical medical status, follow-up times, surgeon’s
experience, use of drains and diagnostic criteria for indec-
tion. Heterogeneity may have been caused by poor study
design. Because of limited information got from original
studies, heterogeneity cannot be completely resolved. Ac-
cordingly, although the results of the meta-analysis should
be considered appropriate, methodological quality defects
and clinical heterogeneity should be considered when
interpreting the findings.
The most important finding of the present meta-anslysis
was that intraarticular steroid injection had statistically
significant effect on the deep infection rates of subsequent
joint arthroplasty but not on superficial infection rates,
suggesting that such practice should not be taken lightly.
Papavasiliou et al. [24] showed a statistically higher deep
infection rate in TKA that had a previous steroid injection
as compared to those who had no previous injection.
However, Desai et al. [21] showed no increased incidence
of deep or superficial infection in TKA after a prior steroid
injection. Meermans et al. found no differences between
the injected and control groups for the rate of deep or
superficial infection in THA.
Steroids can provide symptomatic control in the short
term and may allow surgery to be delayed until a more
appropriate time. The problem is that it is not possible
to predict which patients will respond positively to an
injection. Several studies [13,14] found a greater rate of
infection in THA performed after a previous steroid in-
jection. However, it is unclear which component of theinjection procedure may be culpable: the arthrography
dye, the steroid or its depot vehicle, contamination of
the local anesthetic, the invasiveness of a needle through
prepared skin, any breech of sterile technique, or the
time between the steroid injection and the arthroplasty
[23]. Because of poor study design and limitations, the
GRADE evidence quality for deep and superficial infec-
tion rate was low and very low respectively. Because of
the insufficient quality of evidence, the effect estimate is
uncertain and has a lower GRADE recommendation
strength.
In the present study, the GARDE evidence quality was
very low, which means that we were very uncertain
about the estimates. The lowest GRADE evidence qual-
ity will lower our confidence in recommendation. There-
fore, we would better make clinical decision based on
individual characteristics of the patients.
The primary limitations of this meta-analysis include
the following: (1) the statistical efficacy could be improved
by including more studies. Owing to the finite of included
studies, subgroup analysis can not be performed on TKA
or THA. It may exert instability on consistency of out-
comes. (2) poorly designed retrospective studies were
more likely to suffer from various types of bias. The
pooled results may have significant bias originated from
limitations of original retrospective studies; (3) To some
extent, clinical heterogeneity can not be resolved com-
pletely, such as injection protocols, timing of injections,
number of injections and surgical experience. (4) the over-
all GRADE quality of evidence was very low, which lowers
confidence in any subsequent recommendations. Al-
though we used the GRADE system to evaluate the evi-
dence quality and recommendation strengths, judgment is
still required.Conclusion
From this meta-analysis and grading of the evidence, the
present study offers useful conclusions and demonstrates
that intraarticular steroid injections may lead to increased
deep infection rates of subsequent joint arthroplasty but
not the superficial infection rates. However, the overall
GRADE evidence quality was very low, which will lower
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high-quality studies are still required to validate the results.
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